Theranos Investor Conference Presentation Deck slide image

Theranos Investor Conference Presentation Deck

Lymphocyte Subset: Counts Correlate with Comparator Method 20000 10000 5000 - 2000 miniLab 1000 (cells/μL) 500 200 100 50- Total CD3+ T Cells¹ y = 0.99 x 1.62 = 0.98 n=111 50 Median bias = 0.4% ATE= 19.8% Points within ATE = 96.4% 200 Legend: SEGE= 1000 5000 20000 BD TBNK (cells/μL) Adjusted sample 10000 5000 2000 1000 500 200 100- 50 CD4+ T Cells¹ y = 1.00 x 2.62 r² = 0.98 n=111 50 Median bias = 0.7% ATE=19.6% Points within ATE = 95.5% 200 1000 5000 BD TBNK (cells/μL) Native sample 1 Clin Chim Acta, 2015;438:166-170. Ann Clin Biochem 1997;34:8-12. This technology has not been cleared or approved by the FDA and is not for sale in the United States. 366= - Unity (y = x) 5000 2000 1000 500- 200 100- 50 20 10 10 CD8+ T Cells¹ y = 1.00 x - 0.87 r² = 0.99 n=111 -- Median bias = 1.3% ATE = 21.4% Points within ATE = 97.3% 200 1000 5000 50 330338 BD TBNK (cells/μL) Allowable total error theran s 44
View entire presentation